Navigation Links
CYT003-QbG10 to treat allergy to be presented at the Congress of,the European Academy of Allergology and Clinical Immunology,(EAACI), June 9-13, 2007

illed with a synthetic immunostimulatory DNA sequence called G10. CYT003-QbG10 is designed as a disease-modifying treatment and aims to induce a potent Th1 type immune response in order to suppress an "allergic" Th2 type immune response. An earlier, open-label phase IIa study with CYT003-QbG10 combined with an allergen extract of house dust mites at a standard dose showed excellent long-term efficacy in patients allergic to dust mites. Furthermore, two placebo-controlled phase IIa studies with CYT003-QbG10 delivered positive results in patients suffering from allergic rhinitis due to grass pollen allergy and house dust mite allergy. CYT003-QbG10 is currently being studied in clinical trials for the treatment of allergic rhinitis and atopic dermatitis.

Please feel free to contact us at the address below should you wish to receive further information, address questions, or arrange meetings with Cytos Biotechnology directly.

With best regards,

Claudine Blaser

For more information please contact:

Claudine Blaser, PhD Director Corporate Communications Cytos Biotechnology AG Wagistrasse 25, Postfach CH-8952 Schlieren (Zurich) Tel. +41 44 733 47 20 Fax. +41 44 733 47 18 e-mail: claudine.blaser@cytos.com www.cytos.com


'"/>




Page: 1 2

Related medicine technology :

1. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
2. Placebo-controlled Phase IIa Study with the Immunotherapeutic CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in Hay Fever Patients
3. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
4. Cipralex demonstrates superiority to duloxetine for acute treatment of depression in new study
5. Amsterdam Molecular Therapeutics BV to present preclinical proof-of-concept data on its gene therapy AMT-020 to treat acute intermittent porphyria
6. Basilea Reports Positive Re-treatment Results from a Second Phase III Trial of Alitretinoin for Patients with Severe Chronic Hand Eczema
7. Positive results from placebo-controlled phase IIa study in patients suffering from house dust mite allergy
8. Data to be presented at AAN Meeting -Study results of drug candidate for MS
9. Data supporting three Antisoma programmes presented at AACR
10. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:2/27/2015)... HILL, N.C. , Feb. 27, 2015 ... over the past decade but one thing hasn,t changed: ... MSLs to build relationships with Key Opinion Leaders. ... recognized as the most valuable type of interaction, field ... limits on their KOL interactions. This is just one ...
(Date:2/27/2015)... -- Acsis Inc., the market leader for supply chain visibility, ... John DiPalo , Acsis, Chief Strategy Officer, has been ... 2015 Provider Pro to Know. The award recognizes ... prepare their companies, and customers, supply chains for the ... of Provider Pros to Know is featured in ...
(Date:2/27/2015)... Pharmaceuticals, Inc. (Nasdaq: ISIS ) today announced ... loss (NOL) guidance and its cash guidance ending the ... financial results were due in large part to the ... from its partners.  Isis, pro forma NOL of $16.3 ... its 2013 NOL of $40.2 million. On a GAAP ...
Breaking Medicine Technology:Improving the Management of MSL Teams to Create Value across a Diverse Set of Customers 2Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17
... 2011 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), ... present a company overview at Stifel Nicolaus, Healthcare Conference 2011 ... the Four Seasons Hotel in Boston. A live ... "Investors & Media" section of the Company,s Web site, ...
... People seeking support for healthy good cholesterol ... – and to make a return trip to your ... medical director of Cardiac Rehabilitation and Prevention, John Ochsner ... may not cause flushing, but it has not been ...
Cached Medicine Technology:Leading Expert's Heart Health Advice: Flush Your "Flush-Free" Dietary Supplement Niacin 2Leading Expert's Heart Health Advice: Flush Your "Flush-Free" Dietary Supplement Niacin 3
(Date:3/2/2015)... CA (PRWEB) March 02, 2015 A true ... Eadon, leader of the 1960s cult rock band Khazad Doom, ... by his determination to persevere despite all odds. His motto ... no matter what situation or goal was before him. And ... ’60s, is now being passed on to a new generation. ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 What are ... should physicians request references? When are interviews scheduled, how ... employment opportunities?, Both training and practicing physicians who are ... these questions and more at the PracticeLink Physician Career ... The drop-in Job Fair is from 5:30 to 8:30 ...
(Date:3/2/2015)... Los Angeles, CA (PRWEB) March 02, 2015 ... the face of reported cases of measles. But how ... of children who vaccinated their toddlers to prevent measles, ... 5 days of educational lectures from 150 speakers comprised ... with concerns about the recent news stories and questions ...
(Date:3/2/2015)... Organic Skin Care, the leader in natural, organic and ... of the Balance Collection, an innovative treatment routine designed ... combination skin. The Balancing Masque Duo, presented in a ... products, consists of the Charcoal T-Zone Purifier and the ... a divided jar, contains both the Green Tea T-Zone ...
(Date:3/2/2015)... Secura Consultants announced today the launch ... Insurance Group of Birmingham, AL (First Protective). ... advisors to access the enhanced disability income marketing, ... , Secura Consultants, based in Minneapolis, ... and implementation of insured income protection programs. ...
Breaking Medicine News(10 mins):Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 3Health News:PracticeLink to Host a Career Advancement Workshop and Job Fair in Houston 2Health News:Growing List of Professionals Gather for World’s Most Comprehensive Autism Conference in Chicago, May 2015 2Health News:Éminence Organic Skin Care Launches Innovative Collection for Combination Skin 2Health News:Éminence Organic Skin Care Launches Innovative Collection for Combination Skin 3Health News:Secura Consultants and First Protective Insurance Group Announce Strategic Relationship 2
... bitten by a bat and subsequently diagnosed with rabies has been ... is being offered, the chances of the boy recovering is very ... of Humble High School fell ill last week, unaware of the ... could happen, a bat had flown into his house while he ...
... study conducted by a team at Queeen's has suggested ... when hooked up to dialysis// yield better results in ... ,This five-month, exercise intervention study of dialysis patients ... King-VanVlack, member of the Cardiac, Circulation and Respiratory (CCR) ...
... that more than 80 million American adults are smokers, obese or ... and an early death. // ,Data from a ... of adults in the United States who have one or both ... categories is about 9 million people and this would include a ...
... study states that the organ donation rate in UK is ... relatives are reluctant to allow such procedures. // This was ... potential organ donors because they are distressed and confused about ... ,The UK Transplant, which carried out a two-year audit, ...
... the Japanese Encephalitis immunization drive has not gone down well ... have taken place on June 18, but the government has ... delivery of 5.2 million doses of the Japanese Encephalitis tissue ... , ,The remaining 13.5 million doses are expected to ...
... to place on record the exemplary work of art by students ... effort by Oman in the ‘Unite for children Unite against Aids’ ... ‘Unite for Children Unite Against Aids’ campaign encompasses four major goals ... the percentage of the young victims of HIV/Aids; to provide better ...
Cached Medicine News:Health News:Exercise Combined with Dialysis Yields Better Results 2Health News:Grieving Relatives Reluctant To Give Consent For Organ Donation 2
Inquire...
... versatile 32-bit color mapping software system enhances ... accurate, full color corneal maps. The system ... maps, sagittal maps, refractive and keratometric data, ... phase detection of subclinical keratoconus as well ...
Inquire...
... practice into the future with the ... precision and efficiency, dramatically increase your ... saving time and money. Todays demand ... Topcon EXAM-3000 the logical choice for ...
Medicine Products: